Zai Lab receives Orphan Drug status for ADC for neuroendocrine carcinomas
· seekingalpha.com
US FDA grants Orphan Drug status to Zai Lab’s zocilurtatug pelitecan for neuroendocrine carcinomas, targeting DLL3. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...